Acute myocarditis following COVID-19 mRNA vaccination: a paediatric case
- 2 February 2022
- journal article
- research article
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 32 (7) , 1178-1180
Abstract
Myocarditis is an inflammation of the heart muscle. In this case, a previously healthy, 17-year-old adolescent with myocarditis after BNT162b2 mRNA vaccination was reported. He was admitted to the hospital with severe chest pain, changes in electrocardiography, and elevation in serum troponin level after fourth day of receiving first dose of vaccine. There was no coronary arterial disease in coronary angiogram. A diagnosis of vaccine-induced myocarditis was made, and supportive treatment was initiated.Keywords
This publication has 7 references indexed in Scilit:
- Miocarditis aguda tras administración de vacuna BNT162b2 contra la COVID-19Revista Espanola de Cardiologia, 2021
- Myocarditis following COVID-19 mRNA vaccinationVaccine, 2021
- Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 studyNature Medicine, 2021
- Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018Vaccine, 2021
- Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)JAMA Cardiology, 2020
- Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting SystemInternational Journal of Cardiology, 2018
- Myopericarditis Following Smallpox Vaccination Among Vaccinia-Naive US Military PersonnelJAMA, 2003